Table 4

Prostate-specific antigen staining across metastatic sites for rapid autopsy (RA) cases 3, 14, 24, and 30

Metastatic tissueRA case 3RA case 14RA case 24RA case 30
Adrenal98.54 (98.42–98.89)
Bone47.86 (44.63–51.08)64.92 (57.03–72.82)61.62 (61.62–61.62)60.61 (14.67–77.86)
Bladder2.84 (2.02–3.61)
Dura47.27 (6.25–88.3)2.27 (1.43–2.33)5.84 (5.84–5.84)
Liver39.41 (5.72–77.58)96.03 (94.14–97.58)20.14 (5.85–39.3)
Lung28.93 (7.87–49.09)83.42 (12.43–97.61)2.74 (1.47–95.45)3.59 (0.34–14.07)
Lymph node97 (86.18–98.29)8.57 (8.57–8.57)9.1 (8.53–13.27)
Meninges41.65 (31.83–51.47)
Prostate61.67 (57.49–63.7)4.27 (3.59–4.95)13.05 (11.95–14.16)3.03 (1.2–5.22)
Soft tissue93.77 (83.49–98.61)20.91 (3.91–39.04)
Testis97.79 (97.79–97.79)
  • NOTE. Median % staining of PSA (range). Tables 3 <$REFLINK> and 4 demonstrate heterogeneity in PSA and AR protein expression of metastatic sites in the same patient.